LEF1, WT1 and BCL11B copy number abnormalities were reported from the TARGET study of 2471 pediatric cancer patients whereas in our group we found CDKN2A, CDKN2B and MTAP harboring most copy number variations [42]. The gene discussed is CDKN2B; the disease is cancer.